Citius (CTXR) Expands Scientific Advisory Board. Dr. John Laffey, Expert in Stem Cell and...
- Addition of leading scholar and KOL in acute respiratory distress syndrome (ARDS) to ARDS Scientific Advisory Board supports continued progress of...
Citius (CTXR): Halt For Superiority On The Horizon? (SeekingAlpha).
Jun. 15, 2021 10:41 AM ET Citius Pharmaceuticals, Inc. (CTXR)
Summary
Discontinuing Coverage of PetVivo (PETV), a Gain of 1,035%.
Another 10 Bagger, Bagged.
PetVivo (PETV) is a great little business idea - finally ready to open for...
Adding Cyclerion Thera (CYCN) $3.75, to Biotech Stock Review Watch List.
From the Tiki Hut Fund
Cyclerion Therapeutics Inc (CYCN) | And We Have Deal, Up 30%.
LIVE...
More Great News From Citius Pharma (CTXR).
UPDATED CHART 6-15-21
Mino-Lok® Phase III, FDA NewsRussell 2000 Index NewsTechnical Breakout News
Adding GBT Technologies (GTCH) to the Watch List.
Massive Potential From California Based Technology Think Tank.
Yes, risky - as in...
Adding Auris Medical (EARS) $3.50 to Biotech Watch List.
Auris Medical soared 590% in one Week on Covid Related News on December 1st, 2020.
LIFT OFF...
Hapbee (HAPBF) Selects Accomplished Technology and Consumer Products Entrepreneur & Executive as CEO.
Transformational Entrepreneur Yona Shtern to Lead Hapbee as it Advances Commercialization Phase of Business Development
VANCOUVER, BC, June 2, 2021 /PRNewswire/...
GBT (GTCH) Is Researching To Develop An AI Empowered, Wireless Patient Health Monitoring System
The researched technology, is aiming to create a Radio-Based patient health monitoring system for homes or facilities
SAN...
Stocks On The Move!
Citius (CTXR) up 19%, Draganfly (DFLYF) up 31%, urban-gro (UGRO) up 37%, Provention (PVRB) flip-flopping, Hapbee Technologies (HAPBF) up 26% and the...
Latest article
COVID-19 Immunity From mRNA Booster Does Not Last Very Long.
Study finds that the median length for the antibody half-life immune response was 63 days for the primary series, and increased to...
We’re in Tampa for the Kentucky Derby.
GeoVax (GOVX), Sees a Little Volume.
Normally, we get a little nervous when one of the companies we...
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
